[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global CAR T-Cell Therapy Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

December 2023 | 116 pages | ID: GEB27F89A433EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

CAR T cell therapy refers to the type of cancer treated by injecting T cells engineered with chimeric antigen receptor (CAR) proteins. It involves infusion of engineered T cells to attack tumors or to cause cancer cells. Basically, in this therapy, T cells are collected and redesigned and reinfused into the patient with CAR protein in the laboratory. These T cells now act as attackers of tumor-causing cells.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the CAR T-Cell Therapy market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global CAR T-Cell Therapy market are covered in Chapter 9:
Kite Pharma, Inc.
Pfizer, Inc.
Aurora Biopharma Inc.
Bluebird Bio, Inc.
CARsgen Therapeutics, Ltd.
Mustang Bio, Inc.
Legend Biotech
Sorrento Therapeutics Inc.
Juno Therapeutics
Novartis International AGech
In Chapter 5 and Chapter 7.3, based on types, the CAR T-Cell Therapy market from 2017 to 2027 is primarily split into:
CD 19
CD 20
CD22
CD30
CD33
HER1
HER2
Meso
Egfrvlll
In Chapter 6 and Chapter 7.4, based on applications, the CAR T-Cell Therapy market from 2017 to 2027 covers:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Non Hodgkin Leukemia
Multiple Myeloma
Pancreatic Cancer
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the CAR T-Cell Therapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the CAR T-Cell Therapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 CAR T-CELL THERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of CAR T-Cell Therapy Market
1.2 CAR T-Cell Therapy Market Segment by Type
  1.2.1 Global CAR T-Cell Therapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global CAR T-Cell Therapy Market Segment by Application
  1.3.1 CAR T-Cell Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global CAR T-Cell Therapy Market, Region Wise (2017-2027)
  1.4.1 Global CAR T-Cell Therapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States CAR T-Cell Therapy Market Status and Prospect (2017-2027)
  1.4.3 Europe CAR T-Cell Therapy Market Status and Prospect (2017-2027)
  1.4.4 China CAR T-Cell Therapy Market Status and Prospect (2017-2027)
  1.4.5 Japan CAR T-Cell Therapy Market Status and Prospect (2017-2027)
  1.4.6 India CAR T-Cell Therapy Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia CAR T-Cell Therapy Market Status and Prospect (2017-2027)
  1.4.8 Latin America CAR T-Cell Therapy Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa CAR T-Cell Therapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of CAR T-Cell Therapy (2017-2027)
  1.5.1 Global CAR T-Cell Therapy Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global CAR T-Cell Therapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the CAR T-Cell Therapy Market

2 INDUSTRY OUTLOOK

2.1 CAR T-Cell Therapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 CAR T-Cell Therapy Market Drivers Analysis
2.4 CAR T-Cell Therapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 CAR T-Cell Therapy Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on CAR T-Cell Therapy Industry Development

3 GLOBAL CAR T-CELL THERAPY MARKET LANDSCAPE BY PLAYER

3.1 Global CAR T-Cell Therapy Sales Volume and Share by Player (2017-2022)
3.2 Global CAR T-Cell Therapy Revenue and Market Share by Player (2017-2022)
3.3 Global CAR T-Cell Therapy Average Price by Player (2017-2022)
3.4 Global CAR T-Cell Therapy Gross Margin by Player (2017-2022)
3.5 CAR T-Cell Therapy Market Competitive Situation and Trends
  3.5.1 CAR T-Cell Therapy Market Concentration Rate
  3.5.2 CAR T-Cell Therapy Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL CAR T-CELL THERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global CAR T-Cell Therapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global CAR T-Cell Therapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States CAR T-Cell Therapy Market Under COVID-19
4.5 Europe CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe CAR T-Cell Therapy Market Under COVID-19
4.6 China CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China CAR T-Cell Therapy Market Under COVID-19
4.7 Japan CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan CAR T-Cell Therapy Market Under COVID-19
4.8 India CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India CAR T-Cell Therapy Market Under COVID-19
4.9 Southeast Asia CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia CAR T-Cell Therapy Market Under COVID-19
4.10 Latin America CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America CAR T-Cell Therapy Market Under COVID-19
4.11 Middle East and Africa CAR T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa CAR T-Cell Therapy Market Under COVID-19

5 GLOBAL CAR T-CELL THERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global CAR T-Cell Therapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global CAR T-Cell Therapy Revenue and Market Share by Type (2017-2022)
5.3 Global CAR T-Cell Therapy Price by Type (2017-2022)
5.4 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of CD 19 (2017-2022)
  5.4.2 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of CD 20 (2017-2022)
  5.4.3 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of CD22 (2017-2022)
  5.4.4 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of CD30 (2017-2022)
  5.4.5 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of CD33 (2017-2022)
  5.4.6 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of HER1 (2017-2022)
  5.4.7 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of HER2 (2017-2022)
  5.4.8 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of Meso (2017-2022)
  5.4.9 Global CAR T-Cell Therapy Sales Volume, Revenue and Growth Rate of Egfrvlll (2017-2022)

6 GLOBAL CAR T-CELL THERAPY MARKET ANALYSIS BY APPLICATION

6.1 Global CAR T-Cell Therapy Consumption and Market Share by Application (2017-2022)
6.2 Global CAR T-Cell Therapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global CAR T-Cell Therapy Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global CAR T-Cell Therapy Consumption and Growth Rate of Acute Lymphocytic Leukemia (2017-2022)
  6.3.2 Global CAR T-Cell Therapy Consumption and Growth Rate of Chronic Lymphocytic Leukemia (2017-2022)
  6.3.3 Global CAR T-Cell Therapy Consumption and Growth Rate of Non Hodgkin Leukemia (2017-2022)
  6.3.4 Global CAR T-Cell Therapy Consumption and Growth Rate of Multiple Myeloma (2017-2022)
  6.3.5 Global CAR T-Cell Therapy Consumption and Growth Rate of Pancreatic Cancer (2017-2022)

7 GLOBAL CAR T-CELL THERAPY MARKET FORECAST (2022-2027)

7.1 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global CAR T-Cell Therapy Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global CAR T-Cell Therapy Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global CAR T-Cell Therapy Price and Trend Forecast (2022-2027)
7.2 Global CAR T-Cell Therapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa CAR T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global CAR T-Cell Therapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global CAR T-Cell Therapy Revenue and Growth Rate of CD 19 (2022-2027)
  7.3.2 Global CAR T-Cell Therapy Revenue and Growth Rate of CD 20 (2022-2027)
  7.3.3 Global CAR T-Cell Therapy Revenue and Growth Rate of CD22 (2022-2027)
  7.3.4 Global CAR T-Cell Therapy Revenue and Growth Rate of CD30 (2022-2027)
  7.3.5 Global CAR T-Cell Therapy Revenue and Growth Rate of CD33 (2022-2027)
  7.3.6 Global CAR T-Cell Therapy Revenue and Growth Rate of HER1 (2022-2027)
  7.3.7 Global CAR T-Cell Therapy Revenue and Growth Rate of HER2 (2022-2027)
  7.3.8 Global CAR T-Cell Therapy Revenue and Growth Rate of Meso (2022-2027)
  7.3.9 Global CAR T-Cell Therapy Revenue and Growth Rate of Egfrvlll (2022-2027)
7.4 Global CAR T-Cell Therapy Consumption Forecast by Application (2022-2027)
  7.4.1 Global CAR T-Cell Therapy Consumption Value and Growth Rate of Acute Lymphocytic Leukemia(2022-2027)
  7.4.2 Global CAR T-Cell Therapy Consumption Value and Growth Rate of Chronic Lymphocytic Leukemia(2022-2027)
  7.4.3 Global CAR T-Cell Therapy Consumption Value and Growth Rate of Non Hodgkin Leukemia(2022-2027)
  7.4.4 Global CAR T-Cell Therapy Consumption Value and Growth Rate of Multiple Myeloma(2022-2027)
  7.4.5 Global CAR T-Cell Therapy Consumption Value and Growth Rate of Pancreatic Cancer(2022-2027)
7.5 CAR T-Cell Therapy Market Forecast Under COVID-19

8 CAR T-CELL THERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 CAR T-Cell Therapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of CAR T-Cell Therapy Analysis
8.6 Major Downstream Buyers of CAR T-Cell Therapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the CAR T-Cell Therapy Industry

9 PLAYERS PROFILES

9.1 Kite Pharma, Inc.
  9.1.1 Kite Pharma, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.1.3 Kite Pharma, Inc. Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Pfizer, Inc.
  9.2.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.2.3 Pfizer, Inc. Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Aurora Biopharma Inc.
  9.3.1 Aurora Biopharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.3.3 Aurora Biopharma Inc. Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Bluebird Bio, Inc.
  9.4.1 Bluebird Bio, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.4.3 Bluebird Bio, Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 CARsgen Therapeutics, Ltd.
  9.5.1 CARsgen Therapeutics, Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.5.3 CARsgen Therapeutics, Ltd. Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Mustang Bio, Inc.
  9.6.1 Mustang Bio, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.6.3 Mustang Bio, Inc. Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Legend Biotech
  9.7.1 Legend Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.7.3 Legend Biotech Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Sorrento Therapeutics Inc.
  9.8.1 Sorrento Therapeutics Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.8.3 Sorrento Therapeutics Inc. Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Juno Therapeutics
  9.9.1 Juno Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.9.3 Juno Therapeutics Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Novartis International AGech
  9.10.1 Novartis International AGech Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 CAR T-Cell Therapy Product Profiles, Application and Specification
  9.10.3 Novartis International AGech Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure CAR T-Cell Therapy Product Picture

Table Global CAR T-Cell Therapy Market Sales Volume and CAGR (%) Comparison by Type

Table CAR T-Cell Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global CAR T-Cell Therapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global CAR T-Cell Therapy Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on CAR T-Cell Therapy Industry Development

Table Global CAR T-Cell Therapy Sales Volume by Player (2017-2022)

Table Global CAR T-Cell Therapy Sales Volume Share by Player (2017-2022)

Figure Global CAR T-Cell Therapy Sales Volume Share by Player in 2021

Table CAR T-Cell Therapy Revenue (Million USD) by Player (2017-2022)

Table CAR T-Cell Therapy Revenue Market Share by Player (2017-2022)

Table CAR T-Cell Therapy Price by Player (2017-2022)

Table CAR T-Cell Therapy Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global CAR T-Cell Therapy Sales Volume, Region Wise (2017-2022)

Table Global CAR T-Cell Therapy Sales Volume Market Share, Region Wise (2017-2022)

Figure Global CAR T-Cell Therapy Sales Volume Market Share, Region Wise (2017-2022)

Figure Global CAR T-Cell Therapy Sales Volume Market Share, Region Wise in 2021

Table Global CAR T-Cell Therapy Revenue (Million USD), Region Wise (2017-2022)

Table Global CAR T-Cell Therapy Revenue Market Share, Region Wise (2017-2022)

Figure Global CAR T-Cell Therapy Revenue Market Share, Region Wise (2017-2022)

Figure Global CAR T-Cell Therapy Revenue Market Share, Region Wise in 2021

Table Global CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global CAR T-Cell Therapy Sales Volume by Type (2017-2022)

Table Global CAR T-Cell Therapy Sales Volume Market Share by Type (2017-2022)

Figure Global CAR T-Cell Therapy Sales Volume Market Share by Type in 2021

Table Global CAR T-Cell Therapy Revenue (Million USD) by Type (2017-2022)

Table Global CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)

Figure Global CAR T-Cell Therapy Revenue Market Share by Type in 2021

Table CAR T-Cell Therapy Price by Type (2017-2022)

Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of CD 19 (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD 19 (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of CD 20 (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD 20 (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of CD22 (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD22 (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of CD30 (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD30 (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of CD33 (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD33 (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of HER1 (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of HER1 (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of HER2 (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of HER2 (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of Meso (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of Meso (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate of Egfrvlll (2017-2022)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of Egfrvlll (2017-2022)
Table Global CAR T-Cell Therapy Consumption by Application (2017-2022)

Table Global CAR T-Cell Therapy Consumption Market Share by Application (2017-2022)

Table Global CAR T-Cell Therapy Consumption Revenue (Million USD) by Application (2017-2022)

Table Global CAR T-Cell Therapy Consumption Revenue Market Share by Application (2017-2022)

Table Global CAR T-Cell Therapy Consumption and Growth Rate of Acute Lymphocytic Leukemia (2017-2022)
Table Global CAR T-Cell Therapy Consumption and Growth Rate of Chronic Lymphocytic Leukemia (2017-2022)
Table Global CAR T-Cell Therapy Consumption and Growth Rate of Non Hodgkin Leukemia (2017-2022)
Table Global CAR T-Cell Therapy Consumption and Growth Rate of Multiple Myeloma (2017-2022)
Table Global CAR T-Cell Therapy Consumption and Growth Rate of Pancreatic Cancer (2017-2022)
Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global CAR T-Cell Therapy Price and Trend Forecast (2022-2027)

Figure USA CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa CAR T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa CAR T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global CAR T-Cell Therapy Market Sales Volume Forecast, by Type

Table Global CAR T-Cell Therapy Sales Volume Market Share Forecast, by Type

Table Global CAR T-Cell Therapy Market Revenue (Million USD) Forecast, by Type

Table Global CAR T-Cell Therapy Revenue Market Share Forecast, by Type

Table Global CAR T-Cell Therapy Price Forecast, by Type

Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD 19 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD 19 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD 20 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD 20 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD22 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD22 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD30 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD30 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD33 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of CD33 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of HER1 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of HER1 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of HER2 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of HER2 (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of Meso (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of Meso (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of Egfrvlll (2022-2027)
Figure Global CAR T-Cell Therapy Revenue (Million USD) and Growth Rate of Egfrvlll (2022-2027)
Table Global CAR T-Cell Therapy Market Consumption Forecast, by Application

Table Global CAR T-Cell Therapy Consumption Market Share Forecast, by Application

Table Global CAR T-Cell Therapy Market Revenue (Million USD) Forecast, by Application

Table Global CAR T-Cell Therapy Revenue Market Share Forecast, by Application

Figure Global CAR T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Acute Lymphocytic Leukemia (2022-2027)
Figure Global CAR T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Chronic Lymphocytic Leukemia (2022-2027)
Figure Global CAR T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Non Hodgkin Leukemia (2022-2027)
Figure Global CAR T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Multiple Myeloma (2022-2027)
Figure Global CAR T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Pancreatic Cancer (2022-2027)
Figure CAR T-Cell Therapy Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Kite Pharma, Inc. Profile
Table Kite Pharma, Inc. CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Kite Pharma, Inc. CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Kite Pharma, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Table Aurora Biopharma Inc. Profile
Table Aurora Biopharma Inc. CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aurora Biopharma Inc. CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Aurora Biopharma Inc. Revenue (Million USD) Market Share 2017-2022
Table Bluebird Bio, Inc. Profile
Table Bluebird Bio, Inc. CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bluebird Bio, Inc. CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Bluebird Bio, Inc. Revenue (Million USD) Market Share 2017-2022
Table CARsgen Therapeutics, Ltd. Profile
Table CARsgen Therapeutics, Ltd. CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CARsgen Therapeutics, Ltd. CAR T-Cell Therapy Sales Volume and Growth Rate
Figure CARsgen Therapeutics, Ltd. Revenue (Million USD) Market Share 2017-2022
Table Mustang Bio, Inc. Profile
Table Mustang Bio, Inc. CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mustang Bio, Inc. CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Mustang Bio, Inc. Revenue (Million USD) Market Share 2017-2022
Table Legend Biotech Profile
Table Legend Biotech CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Legend Biotech CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Legend Biotech Revenue (Million USD) Market Share 2017-2022
Table Sorrento Therapeutics Inc. Profile
Table Sorrento Therapeutics Inc. CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sorrento Therapeutics Inc. CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Sorrento Therapeutics Inc. Revenue (Million USD) Market Share 2017-2022
Table Juno Therapeutics Profile
Table Juno Therapeutics CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Juno Therapeutics CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Juno Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Novartis International AGech Profile
Table Novartis International AGech CAR T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis International AGech CAR T-Cell Therapy Sales Volume and Growth Rate
Figure Novartis International AGech Revenue (Million USD) Market Share 2017-2022






More Publications